Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · IEX Real-Time Price · USD
2.140
+0.020 (0.94%)
Jul 22, 2024, 10:00 AM EDT - Market open
Context Therapeutics Employees
Context Therapeutics had 5 employees as of December 31, 2023. The number of employees decreased by 4 or -44.44% compared to the previous year.
Employees
5
Change (1Y)
-4
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$4,264,738
Market Cap
156.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rani Therapeutics Holdings | 140 |
| OptiNose | 132 |
| TriSalus Life Sciences | 112 |
| Kodiak Sciences | 111 |
| Vaxart | 109 |
| Assertio Holdings | 53 |
| Achieve Life Sciences | 22 |
| INmune Bio | 17 |
CNTX News
- 12 days ago - Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 - GlobeNewsWire
- 2 months ago - Context Therapeutics Reports First Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 2 months ago - Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 - GlobeNewsWire
- 4 months ago - Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers - GlobeNewsWire
- 4 months ago - Context Therapeutics Reports Full Year 2023 Operating and Financial Results - GlobeNewsWire
- 9 months ago - Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results - GlobeNewsWire
- 10 months ago - Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - GlobeNewsWire
- 1 year ago - Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results - GlobeNewsWire